Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,999.00
Bid: 1,997.00
Ask: 1,998.00
Change: 34.00 (1.73%)
Spread: 1.00 (0.05%)
Open: 1,991.00
High: 2,028.00
Low: 1,983.00
Prev. Close: 1,965.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Fri, 31st Oct 2014 16:18

UK Earnings, Trading Statements Calendar 
Monday, November 3 
HSBC HoldingsInterim Management Statement
Telecity GroupInterim Management Statement
Tuesday, November 4 
Advanced Computer Software GroupHalf Year Results
Associated British FoodsFull Year Results
Legal & General GroupInterim Management Statement
GlencoreInterim Management Statement
Weir GroupInterim Management Statement
Hilton Food GroupInterim Management Statement
Imperial Tobacco GroupFull Year Results
Jardine Lloyd Thompson GroupInterim Management Statement
PersimmonInterim Management Statement
Unite GroupInterim Management Statement
OneSavings BankInterim Management Statement
888 HoldingsTrading Update
Wednesday, November 5 
Lancashire HoldingsQ3 Results
First DerivativesHalf Year Results
Avocet MiningInterim Management Statement
MeggittInterim Management Statement
Marks & Spencer GroupHalf Year Results
FirstGroupHalf Year Results
Mithras Investment TrustInterim Management Statement
Old MutualInterim Management Statement
JD WetherspoonInterim Management Statement
WincantonInterim Management Statement
HuntingHalf Year Results
MarshallsInterim Management Statement
Drax GroupInterim Management Statement
esure GroupInterim Management Statement
AlentInterim Management Statement
Thursday, November 6 
Promethean WorldInterim Management Statement
Tate & LyleHalf Year Results
Shanks GroupHalf Year Results
Dairy CrestHalf Year Results
Coca-Cola HBC AGQ3 Results
AstraZenecaQ3 Results
STV GroupInterim Management Statement
Croda InternationalInterim Management Statement
DS SmithTrading statement
Costain GroupInterim Management Statement
Intu PropertieInterim Management Statement
ExperianHalf Year Results
BeazleyInterim Management Statement
Cable & Wireless CommunicationsHalf Year Results
Halfords GroupHalf Year Results
InmarsatQ3 Results
London MiningInterim Management Statement
Randgold ResourcesQ3 Results
RightmoveInterim Management Statement
RSA Insurance GroupInterim Management Statement
SchrodersInterim Management Statement
SynthomerInterim Management Statement
WM Morrison SupermarketsInterim Management Statement
Hikma PharmaceuticalsInterim Management Statement
CobhamInterim Management Statement
Stock Spirits GroupInterim Management Statement
SuperGroupTrading statement
Friday, November 7 
Croda InternationalInterim Management Statement
Scottish Mortgage Investment TrustHalf Year Results
Spirax-Sarco EngineeringHalf Year Results
Ark Therapeutics GroupInterim Management Statement
Capital & RegionalInterim Management Statement
Rentokil InitialTrading statement
Admiral GroupInterim Management Statement
National GridHalf Year Results
Capital & Counties PropertiesInterim Management Statement
Bovis Homes GroupInterim Management Statement
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.